{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:43:26Z","timestamp":1786221806711,"version":"build-2736575974"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jns.2026.126078","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:22:19Z","timestamp":1782861739000},"page":"126078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis"],"prefix":"10.1016","volume":"489","author":[{"given":"Maonan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.126078_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.125986","article-title":"No evidence for a causal link between plasma lipids and multiple sclerosis susceptibility and severity: a Mendelian randomisation study","author":"Nagrodzki","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126078_bb0010","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","volume":"8","author":"Burgess","year":"2023","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.jns.2026.126078_bb0015","first-page":"1566","article-title":"Human genetics and drug development","volume":"391","author":"Schmidt","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2026.126078_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-023-03122-7","article-title":"Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study","volume":"25","author":"Xie","year":"2023","journal-title":"Arthrit. Res. Ther."},{"key":"10.1016\/j.jns.2026.126078_bb0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(13)70103-0","article-title":"MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials","volume":"12","author":"Sormani","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2026.126078_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.msard.2015.10.005","article-title":"Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes","volume":"5","author":"Zhornitsky","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2026.126078_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","article-title":"Locus for severity implicates CNS resilience in progression of multiple sclerosis","volume":"619","author":"International Multiple Sclerosis Genetics Consortium and MultipleMS Consortium","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jns.2026.126078_bb0040","first-page":"1105","article-title":"Multiple sclerosis severity heterogeneity: the role of genetic and environmental factors","volume":"148","author":"Claflin","year":"2025","journal-title":"Brain"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26003606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26003606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:08:02Z","timestamp":1786219682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26003606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":8,"alternative-id":["S0022510X26003606"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126078","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126078"}}